{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:07:27Z","timestamp":1790618847847,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115369"],"award-info":[{"award-number":["115369"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejpb.2019.01.021","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T17:37:17Z","timestamp":1548265037000},"page":"147-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir"],"prefix":"10.1016","volume":"136","author":[{"given":"Marlies","family":"Kubbinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio A.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen M.","family":"Wortelboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Verwei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.01.021_b0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10408690390826473","article-title":"Production, properties, and some new applications of chitin and its derivatives","volume":"43","author":"Synowiecki","year":"2003","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ejpb.2019.01.021_b0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijbiomac.2010.05.002","article-title":"Production, physiochemical and antimicrobial properties of fungal chitosan from Rhizomucor miehei and Mucor racemosus","volume":"47","author":"Tajdini","year":"2010","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2019.01.021_b0015","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1021\/jf048202s","article-title":"Physicochemical properties and bioactivity of fungal chitin and chitosan","volume":"53","author":"Wu","year":"2005","journal-title":"J. Agric. Food. Chem."},{"key":"10.1016\/j.ejpb.2019.01.021_b0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jphp.12551","article-title":"Effect of permeability enhancers on paracellular permeability of acyclovir","volume":"68","author":"Ates","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.01.021_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/js980233c","article-title":"Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2)","volume":"88","author":"Kotze","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0030","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/jps.23170","article-title":"In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats","volume":"101","author":"Masuda","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/10837450701555901","article-title":"Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2)","volume":"12","author":"Opanasopit","year":"2007","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2019.01.021_b0040","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1012160102740","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.01.021_b0045","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1080\/03639040902774156","article-title":"Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats","volume":"35","author":"Merzlikine","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2019.01.021_b0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/03639040701655952","article-title":"In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers","volume":"34","author":"Shah","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2019.01.021_b0055","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1248\/bpb.29.1941","article-title":"Effect of chitosan on gastrointestinal absorption of water-insoluble drugs following oral administration in rats","volume":"29","author":"Nadai","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2019.01.021_b0060","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.biomaterials.2004.06.020","article-title":"Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption","volume":"26","author":"Smith","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2019.01.021_b0065","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1023\/A:1016444808000","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs. 1: influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells","volume":"13","author":"Schipper","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.01.021_b0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0928-0987(99)00032-9","article-title":"Chitosans as absorption enhancers of poorly absorbable drugs. 3: influence of mucus on absorption enhancement","volume":"8","author":"Schipper","year":"1999","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0075","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1021\/mp400179v","article-title":"Ion pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chloride","volume":"10","author":"Heinen","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.01.021_b0080","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s11095-014-1613-y","article-title":"The influence of chitosan on the oral bioavailability of acyclovir \u2013 a comparative bioavailability study in humans","volume":"32","author":"Kubbinga","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.01.021_b0085","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1002\/jps.21392","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: aciclovir","volume":"97","author":"Arnal","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejpb.2010.10.009","article-title":"Food-dependent disintegration of immediate release fosamprenavir tablets: in vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system","volume":"77","author":"Brouwers","year":"2011","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.ejpb.2019.01.021_b0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1208\/s12248-012-9333-x","article-title":"An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence of poorly soluble drugs","volume":"14","author":"Dickinson","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2019.01.021_b0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/026119299502300205","article-title":"Multicompartmental dynamic computer-controlled model simulating the stomach and small intestine","volume":"23","author":"Minekus","year":"1995","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2019.01.021_b0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejps.2014.11.010","article-title":"Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF","volume":"67","author":"Wuyts","year":"2015","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0110","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2013.03.010","article-title":"Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans","volume":"85","author":"Heinen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm.: Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.ejpb.2019.01.021_b0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejps.2014.07.003","article-title":"A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices","volume":"63","author":"Westerhout","year":"2014","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0120","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1023\/A:1011927521627","article-title":"Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport","volume":"15","author":"Shojaei","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.01.021_b0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(99)00030-7","article-title":"Effect of chitosan on epithelial permeability and structure","volume":"182","author":"Dodane","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.01.021_b0130","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jps.24274","article-title":"Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap((R)) system","volume":"104","author":"Koziolek","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0135","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1002\/jps.20888","article-title":"Modulation of ganciclovir intestinal absorption in presence of absorption enhancers","volume":"96","author":"Shah","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0140","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/jps.1127","article-title":"Effect of common excipients on Caco-2 transport of low-permeability drugs","volume":"90","author":"Rege","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2006.01.001","article-title":"Protonation constants of chitosan with different molecular weight and degree of deacetylation","volume":"65","author":"Wang","year":"2006","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2019.01.021_b0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.progpolymsci.2009.04.001","article-title":"Chitin and chitosan polymers: chemistry, solubility and fiber formation","volume":"34","author":"Pillai","year":"2009","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1208\/s12248-013-9456-8","article-title":"Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements","volume":"15","author":"Larregieu","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2019.01.021_b0160","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jps.21010","article-title":"Variability in Caco-2 and MDCK cell-based intestinal permeability assays","volume":"97","author":"Volpe","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5173(98)00027-1","article-title":"In vitro evaluation of the mucoadhesive properties of chitosan microspheres","volume":"166","author":"He","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.01.021_b0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.2042-7158.1997.tb06084.x","article-title":"Human jejunal effective permeability and its correlation with preclinical drug absorption models","volume":"49","author":"Lennern\u00e4s","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.01.021_b0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption \u2013 comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Sjogren","year":"2014","journal-title":"Eur. J. Pharm. Sci.: Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0180","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/js970218s","article-title":"Membrane transport of drugs in different regions of the intestinal tract of the rat","volume":"87","author":"Ungell","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2019.01.021_b0185","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jps.24643","article-title":"Effect of common excipients on the oral drug absorption of biopharmaceutics classification system class 3 drugs cimetidine and acyclovir","volume":"105","author":"Vaithianathan","year":"2016","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117314856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117314856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:33:49Z","timestamp":1760546029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117314856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"alternative-id":["S0939641117314856"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.021","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}